First published: 23rd May 2023

We are excited to announce our plans to present data at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, gathered via repeated sampling of at-home and in-clinic data using the portable Cumulus neurocognitive platform.

Titled "Electrophysiological Correlates of a Ketamine Infusion Captured via the Portable Cumulus Neurocognitive Platform Using Repeated Sampling from the Clinic and the Home," the poster presentation was accepted by the ASCP Program Committee as part of its annual meeting exploring key aspects of neuropsychiatric drug development.

"Bridging the gap between preclinical studies and first-in-human studies is challenging with conventional methods – researchers need a way to assess drug engagement when an experimental compound is administered for the first time," said Brian Murphy, PhD, Founder and Chief Scientific Officer of Cumulus. "Our clinical-grade digital biomarkers enable researchers to track these effects directly, as well as the mechanistic and functional effects in the days and weeks afterwards, in-home. These tools can enhance scientists' confidence in progressing new psychiatric drugs to trials with patients, so that new therapies reach those in need, sooner."

The ASCP Annual Meeting takes place in Miami, Florida from May 30-June 2, 2023. Cumulus poster presentation details are as follows:

• Poster: "Electrophysiological Correlates of a Ketamine Infusion Captured via the Portable Cumulus Neurocognitive Platform Using Repeated Sampling from the Clinic and the Home"
• Session Title: Poster Session I
• Date and Time: Wednesday, May 31, 2023, at 11:15am-1pm ET
• Location and Board Number: Salon 4, Poster Board W12